Pregnancy, subclinical hypohyroidism and thyroid antibodies
This preview paper which will soon become completely in print shows that new evidence is making the US authorities on the treatment of pregnancy rethink their guidance sooner than they normally do. I present this not just because it may be important for thyroid treatment in pregnancy, but that this rethink might force the authorities to rethink in other situations such as Hashimoto's and hypothyroidism/treatment. Progress is coming fast to encourage this rethink. I don't think this will apply to the UK, because the new NICE guidelines produced by hidebound, restricted-analytic and partial evidence from out-of-date physicians (who of highest calibre would go into thyroid, when genetics is the whizz field nowadays) will be stubbornly defended.
SYSTEMATIC REVIEW ARTICLE
Front. Endocrinol. | doi: 10.3389/fendo.2020.00193
The Need for Dynamic Clinical Guidelines: A Systematic Review of New Research Published After Release of the 2017 ATA Guidelines on Thyroid Disease during Pregnancy and the Postpartum Provisionally accepted The final, formatted version of the article will be published soon. Notify me
Allan C. Dong1, Mary D. Stephenson and Alex S. Stagnaro-Green